Does daily high-potency cannabis use lead to more psychotic symptoms?
The large EU-GEI study of 901 first-episode psychosis patients and 1,235 controls found a linear relationship between cannabis exposure and positive symptoms, with daily high-potency users showing the most severe positive symptoms and fewer negative symptoms.
Quick Facts
What This Study Found
In patients, daily high-potency cannabis use was associated with the highest positive symptom scores (B=0.35, 95% CI 0.14-0.56) in a dose-response pattern. Patients who never used cannabis had more negative symptoms than any cannabis-using group (B=-0.22, 95% CI -0.37 to -0.07). In controls, psychotic experiences correlated with current use but not lifetime exposure. No depression differences related to cannabis were found in either group.
Key Numbers
901 FEP patients; 1,235 controls; 6 countries; daily high-potency use and positive symptoms B=0.35; never-use and negative symptoms B=-0.22; no association with depressive dimension
How They Did This
Cross-sectional case-control study from EU-GEI analyzing 901 FEP patients and 1,235 controls across six countries. Item response bifactor modeling generated symptom dimensions. Associations tested via linear mixed-effects models.
Why This Research Matters
This is the first large-scale evidence that cannabis potency and frequency interact to shape the symptom profile of first-episode psychosis. The dose-response relationship with positive symptoms strengthens the case for a causal contribution of cannabis to psychosis.
The Bigger Picture
The finding that cannabis use is associated with fewer negative symptoms alongside more positive symptoms may explain why some patients perceive cannabis as beneficial. They may experience reduced social withdrawal while their positive symptoms (hallucinations, delusions) actually worsen.
What This Study Doesn't Tell Us
Cross-sectional design limits causal inference. Self-reported cannabis use patterns and potency. Potency definitions varied across countries. Patients were recruited after psychosis onset, so pre-illness cannabis patterns are retrospectively reported.
Questions This Raises
- ?Could the inverse relationship with negative symptoms reflect self-medication for anhedonia?
- ?Would reducing cannabis potency through regulation change psychosis symptom profiles?
- ?Do these dose-response patterns inform prevention strategies?
Trust & Context
- Key Stat:
- 901 patients across 6 countries
- Evidence Grade:
- Large multicentric study with sophisticated statistical modeling, though cross-sectional design limits causal claims.
- Study Age:
- Published in 2021; EU-GEI remains one of the most comprehensive studies of cannabis and psychosis.
- Original Title:
- Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
- Published In:
- Psychological medicine, 51(8), 1329-1337 (2021)
- Authors:
- Quattrone, Diego(18), Ferraro, Laura(13), Tripoli, Giada(14), La Cascia, Caterina, Quigley, Harriet, Quattrone, Andrea, Jongsma, Hannah E, Del Peschio, Simona, Gatto, Giusy, Gayer-Anderson, Charlotte, Jones, Peter B, Kirkbride, James B, La Barbera, Daniele, Tarricone, Ilaria, Berardi, Domenico, Tosato, Sarah, Lasalvia, Antonio, Szöke, Andrei, Arango, Celso, Bernardo, Miquel, Bobes, Julio, Del Ben, Cristina Marta, Menezes, Paulo Rossi, Llorca, Pierre-Michel, Santos, Jose Luis, Sanjuán, Julio, Tortelli, Andrea, Velthorst, Eva, de Haan, Lieuwe, Rutten, Bart P F, Lynskey, Michael T, Freeman, Tom P, Sham, Pak C, Cardno, Alastair G, Vassos, Evangelos, van Os, Jim, Morgan, Craig, Reininghaus, Ulrich, Lewis, Cathryn M, Murray, Robin M, Di Forti, Marta
- Database ID:
- RTHC-03445
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does stronger cannabis cause worse psychosis?
This study found a dose-response relationship: daily use of high-potency cannabis was associated with the most severe positive symptoms, while occasional or low-potency use showed lesser associations.
Why might cannabis reduce negative symptoms?
Cannabis users had fewer negative symptoms (like social withdrawal and flat affect) compared to non-users. This could reflect self-medication, or it could mean that people with fewer negative symptoms are more socially engaged and thus more likely to use cannabis.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03445APA
Quattrone, Diego; Ferraro, Laura; Tripoli, Giada; La Cascia, Caterina; Quigley, Harriet; Quattrone, Andrea; Jongsma, Hannah E; Del Peschio, Simona; Gatto, Giusy; Gayer-Anderson, Charlotte; Jones, Peter B; Kirkbride, James B; La Barbera, Daniele; Tarricone, Ilaria; Berardi, Domenico; Tosato, Sarah; Lasalvia, Antonio; Szöke, Andrei; Arango, Celso; Bernardo, Miquel; Bobes, Julio; Del Ben, Cristina Marta; Menezes, Paulo Rossi; Llorca, Pierre-Michel; Santos, Jose Luis; Sanjuán, Julio; Tortelli, Andrea; Velthorst, Eva; de Haan, Lieuwe; Rutten, Bart P F; Lynskey, Michael T; Freeman, Tom P; Sham, Pak C; Cardno, Alastair G; Vassos, Evangelos; van Os, Jim; Morgan, Craig; Reininghaus, Ulrich; Lewis, Cathryn M; Murray, Robin M; Di Forti, Marta. (2021). Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.. Psychological medicine, 51(8), 1329-1337. https://doi.org/10.1017/S0033291720000082
MLA
Quattrone, Diego, et al. "Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.." Psychological medicine, 2021. https://doi.org/10.1017/S0033291720000082
RethinkTHC
RethinkTHC Research Database. "Daily use of high-potency cannabis is associated with more p..." RTHC-03445. Retrieved from https://rethinkthc.com/research/quattrone-2021-daily-use-of-highpotency
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.